Jim Cramer Talked About These 17 Stocks After The Fed’s Rate Cut

6. McKesson Corporation (NYSE:MCK)

Number of Hedge Fund Holders In Q3 2024: 57

McKesson Corporation (NYSE:MCK) is one of the many American pharmacy and healthcare benefits management firms that have struggled in 2024. Like CVS, the firm hasn’t impressed investors even before the recent momentum build-up against the healthcare industry. McKesson Corporation (NYSE:MCK)’s shares fell by 12% in August after its $71.7 billion in pharmaceutical revenue missed analyst estimates of $74.1 billion. However, the stock soared by 16% in November after it raised full-year guidance. Over the past month though McKesson Corporation (NYSE:MCK)’s shares have lost 7% due to worries of government action against the healthcare ‘middlemen.’ Here’s what Cramer said:

“Look I think that if I were the people at McKesson, Cencora, when the President-elect decides that he is going to take a shot at you, as we know from his first time around, it’s not one off. There’s multiple shots. Multiple attempts to say listen you guys are . . . friction. I would not buy these stocks. I would not buy McKesson. I think that they David, as much people want to look at reverse head and shoulders there [MCK SHARE PRICE GRAPH] and buy it, I think you are in cross, in the crosses of President-elect Trump and then Musk, I mean these guys are powerful one-two combination. You know. This is one where I look at McKesson I think there goes Frazier! there goes Frazier!”